China
Africa
Explore chapters and articles related to this topic
Research Institutions, Grant Funding Sources, Federal Agencies, and Education and Training Centers
Published in Jeffrey T. Huber, How to Find Information About AIDS, 2019
Research funding in the AIDS arena is generally supplied by various agencies within the Federal Government. The private sector has continued to increase its support in this area, however, either through direct subsidies or through the coordination of grant monies. This section presents a listing of resources that provide grant funding, organizations that actively support research, federally funded education and training centers, and federal agencies that provide funding, conduct research, or coordinate AIDS-related services nationwide. The federally funded AIDS Education and Training Centers were established to train health care professionals working with AIDS throughout the U.S. The AIDS Clinical Trials section of the National AIDS Information Clearinghouse or the AIDS CLINICAL TRIALS file of the National Library of Medicine’s databases hold more comprehensive information on current clinical trials. The National Institutes of Health Guide for Grants and Contracts provides more detailed information related to grant funding.
Symptoms of generalized anxiety disorder as a risk factor for substance use among adults living with HIV
Published in AIDS Care, 2021
Zachary L. Mannes, Eugene M. Dunne, Erin G. Ferguson, Robert L. Cook, Nicole Ennis
Among the most commonly reported symptoms of GAD in this sample were worrying and feelings of anxiety. Given this, it is critical that appropriate anxiety management recommendations are provided, which may include cognitive behavioral therapy and/or psychotropic medications (Stefan et al., 2019). Cognitive behavioral therapy with a focus on exposure and response prevention strategies is effective for patients with anxiety disorders and has promising results in the context of comorbid substance use concerns (Lee & Oei, 1993). An integrated cognitive behavioral therapy approach specifically adapted for patients living with HIV demonstrated a reduction in anxiety symptoms while improving HIV medication adherence (Brandt et al., 2017). Regarding psychotropic medication, common medications used to treat anxiety disorders include benzodiazepines, venlafaxine, and buspirone (American Psychiatric Association, 2012). However, it is critical that prescribing clinicians consider drug-drug interactions and potential side effects if such psychotropic medications are prescribed. Finally, collaborative care models or co-location of services, in which medical, mental health, and other ancillary services (e.g., substance use treatment, case management) partner to provide care, may be useful to address anxiety and substance use among PLWH (Mizuno et al., 2019). This is supported by the Ryan White HIV/AIDS Program AIDS Education and Training Centers (AETCs) National Curriculum, which emphasizes the necessity of clinician screening efforts and integration of mental health care into HIV primary care (Budak & Cournos, 2020).
Discrimination in healthcare settings among adults with recent HIV diagnoses
Published in AIDS Care, 2019
Amy R. Baugher, Linda Beer, Jennifer L. Fagan, Christine L. Mattson, R. Luke Shouse
RWHAP facilities serve low-income PLWH and incorporate anti-discrimination and cultural competency in staff training (HRSA). RWHAP funds the AIDS Education and Training Centers (AETCs), which provide HIV education and training for providers and clinic staff (Johnson, 2011). AETC programs have reduced HIV stigma among clinic staff (Mulligan, Seirawan, Galligan, & Lemme, 2006). Further, quality improvement activities, which hold programs to the same standards, are required of RWHAP-funded programs (Agins, 2014). It is possible that RWHAP trainings and quality requirements contribute to lower discrimination. Non-RWHAP facilities may benefit from similar anti-discrimination trainings and quality improvement activities.